MTA2 and chronic kidney disease: In decreasing aggregate p, Regulation of nuclear SMAD2/3 signaling (originating from PID) emerges as the most noteworthy pathway, showing p values 0.012, 0.0010, and 0.0020 in CKD, GSE62792, and GSE37171, respectively.